The development of humoral immunity to tissue-specific tubular basement membrane alloantigens after renal transplantation across the major histocompatibility barrier in rats immunomodulated with blood transfusions and cyclosporin.
The development of a humoral immune response to the tubular basement membrane (TBM) alloantigen of Brown-Norway (BN) rat kidneys was studied after transplantation of BN rat kidneys into bilaterally nephrectomized Lewis (LEW) rats. The LEW rat recipients consisted of four groups receiving no form of immunosuppression, pretransplantation cyclosporin alone, or pretransplantation donor-specific or donor-nonspecific transfusions combined with cyclosporin. The latter two regimens induce indefinite allograft survival in the majority of recipients. Circulating antibody to collagenase-solubilized BN rat renal basement membrane (CS-BN-RBM) was present in all four groups of transplant recipients within 1 week after transplantation, and no significant differences in antibody levels were noted between rats receiving no immunosuppression (survival of 1-2 weeks) and the groups of rats who received various immunosuppressive regimens and survived longer. Circulating antibody to BN-CS-RBM continued to increase in quantity in the cyclosporin-treated group until the time of death (2-10 weeks post-transplantation). In the much longer lived combined transfusion and cyclosporin-treated groups, circulating antibody to BN-CS-RBM generally attained a maximum at approximately 2 to 4 months post-transplantation and then plateaued or decreased somewhat before the time of death (3-16 months post-transplantation). No correlation was found between quantity of circulating anti-BN-CS-RBM antibody and post-transplantation survival. Comparative study of the quantity of circulating antibody to BN-CS-RBM (the presumed nephritogenic antigen of experimental tubulointerstitial nephritis in the BN rat) in serum from transplant recipients as compared to serum from BN rats with severe experimental tubulointerstitial nephritis (TIN) (as induced by immunization with heterologous TBM antigens) demonstrated a greater quantity of potentially nephritogenic antibody circulating in transplant recipients than in BN rats with experimental TIN. Histologically, the transplanted kidneys in immunomodulated recipients demonstrated focal chronic interstitial inflammatory infiltrates with tubular atrophy and relative sparing of the glomeruli. The development of immune responses to tissue-specific alloantigens may become of clinical significance as graft-survival times are increased.
Ulich
T R
TR
Department of Pathology, University of California at Irvine Medical School 92717.
Ni
R X
RX
Hewitt
C W
CW
Black
K S
KS
Go
C
C
Martin
D C
DC
D000818:Animals; D000917:Antibody Formation; D000954:Antigens, Surface / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis; D001485:Basement Membrane / Q000276:immunology; D001803:Blood Transfusion; D003524:Cyclosporins / Q000627:therapeutic use; D006085:Graft Survival; D006649:Histocompatibility Antigens / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology; D007165:Immunosuppression Therapy; D007519:Isoantigens / Q000276:immunology*; D007668:Kidney / Q000473:pathology; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000276:immunology*; D009393:Nephritis / Q000276:immunology / Q000473:pathology; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew
D000954:Antigens, Surface; D001323:Autoantibodies; D003524:Cyclosporins; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007519:Isoantigens